Moana Tercel

1.3k total citations
52 papers, 1.0k citations indexed

About

Moana Tercel is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Moana Tercel has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Organic Chemistry and 21 papers in Cancer Research. Recurrent topics in Moana Tercel's work include Cancer, Hypoxia, and Metabolism (20 papers), Cancer therapeutics and mechanisms (14 papers) and Synthesis and Biological Evaluation (10 papers). Moana Tercel is often cited by papers focused on Cancer, Hypoxia, and Metabolism (20 papers), Cancer therapeutics and mechanisms (14 papers) and Synthesis and Biological Evaluation (10 papers). Moana Tercel collaborates with scholars based in New Zealand, Germany and United States. Moana Tercel's co-authors include William A. Denny, William R. Wilson, Robert F. Anderson, Frederik B. Pruijn, Ralph J. Stevenson, Graham J. Atwell, David C. Ware, G‐One Ahn, Maruta Boyd and H.D. Sarath Liyanage and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Chemical Physics Letters.

In The Last Decade

Moana Tercel

52 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moana Tercel New Zealand 22 570 475 269 224 133 52 1.0k
Kevin G. Pinney United States 27 654 1.1× 1.3k 2.8× 266 1.0× 272 1.2× 181 1.4× 85 2.0k
Gregory P. Roth United States 25 645 1.1× 1.2k 2.5× 80 0.3× 182 0.8× 125 0.9× 64 1.9k
William A. Denny New Zealand 18 640 1.1× 731 1.5× 164 0.6× 361 1.6× 58 0.4× 21 1.4k
Krishnamurthy Shyam United States 21 602 1.1× 231 0.5× 257 1.0× 139 0.6× 101 0.8× 46 937
R. M. Garbaccio United States 22 959 1.7× 1.2k 2.5× 105 0.4× 130 0.6× 101 0.8× 40 1.9k
Reshma Rani India 17 784 1.4× 480 1.0× 592 2.2× 231 1.0× 59 0.4× 42 1.5k
Michael J. Broadhurst United Kingdom 20 391 0.7× 459 1.0× 264 1.0× 275 1.2× 42 0.3× 52 1.2k
Susan M. Pullen New Zealand 19 528 0.9× 248 0.5× 346 1.3× 190 0.8× 118 0.9× 25 953
Michael J. Grogan United States 14 924 1.6× 705 1.5× 115 0.4× 362 1.6× 46 0.3× 18 1.8k
Keizo Koya United States 19 627 1.1× 406 0.9× 102 0.4× 205 0.9× 47 0.4× 31 1.2k

Countries citing papers authored by Moana Tercel

Since Specialization
Citations

This map shows the geographic impact of Moana Tercel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moana Tercel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moana Tercel more than expected).

Fields of papers citing papers by Moana Tercel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moana Tercel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moana Tercel. The network helps show where Moana Tercel may publish in the future.

Co-authorship network of co-authors of Moana Tercel

This figure shows the co-authorship network connecting the top 25 collaborators of Moana Tercel. A scholar is included among the top collaborators of Moana Tercel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moana Tercel. Moana Tercel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Tet Woo, Dean C. Singleton, Moana Tercel, et al.. (2024). Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models. Molecular Oncology. 18(8). 1885–1903. 1 indexed citations
2.
Sharrock, Abigail V., Jeff S. Mumm, Ian F. Hermans, et al.. (2021). Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System. Frontiers in Pharmacology. 12. 701456–701456. 11 indexed citations
5.
Hunter, Francis W., Jagdish K. Jaiswal, Daniel Hurley, et al.. (2014). The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs. Biochemical Pharmacology. 89(2). 224–235. 22 indexed citations
6.
Chang, John Yu-Chih, Guo‐Liang Lu, Ralph J. Stevenson, et al.. (2013). Cross-Bridged Cyclen or Cyclam Co(III) Complexes Containing Cytotoxic Ligands as Hypoxia-Activated Prodrugs. Inorganic Chemistry. 52(13). 7688–7698. 38 indexed citations
7.
Ashoorzadeh, Amir, Graham J. Atwell, Frederik B. Pruijn, et al.. (2011). The effect of sulfonate leaving groups on the hypoxia-selective toxicity of nitro analogs of the duocarmycins. Bioorganic & Medicinal Chemistry. 19(16). 4851–4860. 7 indexed citations
8.
Tercel, Moana, Ho H. Lee, Shangjin Yang, et al.. (2011). Preparation and Antitumour Properties of the Enantiomers of a Hypoxia‐Selective Nitro Analogue of the Duocarmycins. ChemMedChem. 6(10). 1860–1871. 10 indexed citations
9.
Tercel, Moana, Graham J. Atwell, Shangjin Yang, et al.. (2011). Selective Treatment of Hypoxic Tumor Cells In Vivo: Phosphate Pre‐Prodrugs of Nitro Analogues of the Duocarmycins. Angewandte Chemie International Edition. 50(11). 2606–2609. 39 indexed citations
10.
Stevenson, Ralph J., et al.. (2011). The effect of a bromide leaving group on the properties of nitro analogs of the duocarmycins as hypoxia-activated prodrugs and phosphate pre-prodrugs for antitumor therapy. Bioorganic & Medicinal Chemistry. 19(20). 5989–5998. 4 indexed citations
11.
Tercel, Moana, Ralph J. Stevenson, Guo‐Liang Lu, et al.. (2011). Weight loss effects of quaternary salts of 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles; structure–activity relationships. Bioorganic & Medicinal Chemistry. 20(2). 734–749. 3 indexed citations
12.
Lu, Guo‐Liang, Ralph J. Stevenson, John Yu-Chih Chang, et al.. (2011). N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs. Bioorganic & Medicinal Chemistry. 19(16). 4861–4867. 19 indexed citations
13.
14.
Wilson, William R., Stephen M. Stribbling, Frederik B. Pruijn, et al.. (2009). Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N 3 DNA minor groove alkylators. Molecular Cancer Therapeutics. 8(10). 2903–2913. 29 indexed citations
16.
Ahn, G‐One, et al.. (2006). Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator. Biochemical Pharmacology. 71(12). 1683–1694. 67 indexed citations
17.
Tercel, Moana, Stephen M. Stribbling, Hilary M. Sheppard, et al.. (2003). Unsymmetrical DNA Cross-Linking Agents:  Combination of the CBI and PBD Pharmacophores. Journal of Medicinal Chemistry. 46(11). 2132–2151. 54 indexed citations
18.
Tercel, Moana, William Wilson, & William A. Denny. (1995). Hypoxia-Selective Antitumor Agents. 11. Chlorambucil N-Oxide: A Reappraisal of Its Synthesis, Stability, and Selective Toxicity for Hypoxic Cells. Journal of Medicinal Chemistry. 38(7). 1247–1252. 14 indexed citations
19.
Denny, William A., William R. Wilson, Moana Tercel, Pierre van Zijl, & Susan M. Pullen. (1994). Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxins capable of releasing diffusible cytotoxins on bioreduction. International Journal of Radiation Oncology*Biology*Physics. 29(2). 317–321. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026